Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative NeoplasmsDebra Van Egeren, Sahand Hormoz, Javier Escabi et al.|Cell stem cell|2021Cited by 209
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapyJeremy S. Abramson, Andrew M. Evens, André Goy et al.|Annals of Oncology|2014Cited by 138
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settingsJacqueline S. Garcia, Robert J. Soiffer, Yael Flamand et al.|Blood|2022Cited by 51
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A. Lane, Naveen Pemmaraju, Jacqueline S. Garcia et al.|Blood Advances|2023Cited by 45
Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve SettingsJacqueline S. Garcia, Robert J. Soiffer, Yael Flamand et al.|Blood|2020Cited by 12